In a 26-week study, orforglipron demonstrated a significant dose-dependent effect on weight loss, with weight reduction ranging from 8.6% to 12.6% across various dosages, compared to only 2.0% in the placebo group
For this product-page article, RUO means the language stays focused on laboratory research, documentation review, and analytical verification
Wegovy is administered as a once-weekly injection under the skin (subcutaneous injection) and is available in an easy-to-use, pre-filled pen device
Individual response varies based on genetics, drinking history, the specific medication and dose, and co-occurring conditions
Impact on Daily Life When side effects start to interfere with your usual routine or affect your nutritional intake significantly, reaching out for medical assistance is critical